$PHR News

Barclays Maintains Equal-Weight on Phreesia, Raises Price Target to $11

Phreesia’s Michael Rasbury Named to Becker’s 2026 List of Rising Stars: Healthcare Leaders Under 40

Phreesia to Support Parkinson’s Disease Awareness and Research with The Michael J. Fox Foundation

Phreesia Named to TIME’s 2026 List of the World’s Top HealthTech Companies

Wall Street Splits on Phreesia (PHR) as Margins Improve but Growth Visibility Fades

Phreesia’s ProviderConnect Audiences are Now Available in the DeepIntent Audience Marketplace

Phreesia’s (PHR) Profit Turnaround Meets A Cash-Strapped Client Base

Phreesia (PHR) Q2 2027 Earnings Call Transcript

Raymond James Downgrades Phreesia to Market Perform

Phreesia, Inc. 2027 Q2 - Results - Earnings Call Presentation

DA Davidson Maintains Buy on Phreesia, Lowers Price Target to $13

Baird Maintains Neutral on Phreesia, Raises Price Target to $11

Phreesia Files Shelf Prospectus For Offering; Size Not Disclosed

Phreesia, Inc. Q2 2027 Earnings Call Summary

These Analysts Revise Their Forecasts On Phreesia After Q2 Results

RBC Capital Reiterates Outperform on Phreesia, Maintains $19 Price Target

Wells Fargo Maintains Equal-Weight on Phreesia, Raises Price Target to $10

Needham Reiterates Buy on Phreesia, Maintains $14 Price Target

Phreesia Inc (PHR) (Q2 2027) Earnings Call Highlights: Record EBITDA Margin and Strategic ...

Phreesia Q2 Earnings Call Highlights